21
Participants
Start Date
May 24, 2018
Primary Completion Date
December 31, 2025
Study Completion Date
January 10, 2026
ZTI-01 100 mg/kg
ZTI-01 intravenous (IV)
ZTI-01 75 mg/kg
ZTI-01 intravenous (IV)
RECRUITING
Kosair Charities Pediatric Clinical Research Unit, Louisville
RECRUITING
Children's Hospital of Michigan, Detroit
RECRUITING
University of New Mexico Hospital, Albuquerque
RECRUITING
Rady Children's Hospital, San Diego
RECRUITING
Children's Hospital of Orange County, Orange
Lead Sponsor
Nabriva Therapeutics AG
INDUSTRY